Citation Impact
Citing Papers
Pathophysiology of Migraine: A Disorder of Sensory Processing
2017 Standout
Normal gut microbiota modulates brain development and behavior
2011 Standout
A Meta-Analysis of Cytokines in Major Depression
2009 Standout
Effects of Psilocybin-Assisted Therapy on Major Depressive Disorder
2020 Standout
Trial of Psilocybin versus Escitalopram for Depression
2021 Standout
Differential physiological effects of a low dose and high doses of venlafaxine in major depression
2006
Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis
2018 Standout
Neurovascular and neuroimaging effects of the hallucinogenic serotonin receptor agonist psilocin in the rat brain
2015
Depression
2018 Standout
Histopathology of the prefrontal cortex in major depression: what does it tell us about dysfunctional monoaminergic circuits?
2000
Pre-treatment with the mGlu2/3 receptor agonist LY379268 attenuates DOI-induced impulsive responding and regional c-Fos protein expression
2011
Sex Differences in the Regulation of Serotonergic Transmission and Behavior in 5-HT Receptor Knockout Mice
2005
Metalearning and neuromodulation
2002
RIM1α and Interacting Proteins Involved in Presynaptic Plasticity Mediate Prepulse Inhibition and Additional Behaviors Linked to Schizophrenia
2010 StandoutNobel
Serotonergic/glutamatergic interactions: the effects of mGlu 2/3 receptor ligands in rats trained with LSD and PCP as discriminative stimuli
2004
Acceleration of the effect of selected antidepressant drugs in major depression by 5-HT1A antagonists
1996
Genetic variation in cortico-amygdala serotonin function and risk for stress-related disease
2008
Differential effects of adjunctive methylphenidate and citalopram on extracellular levels of serotonin, noradrenaline and dopamine in the rat brain
2007
The Serotonin-1A Receptor in Anxiety Disorders
2009
Maternal Immune Activation Alters Fetal Brain Development through Interleukin-6
2007 Standout
Enriched Expression of Serotonin 1B and 2A Receptor Genes in Macaque Visual Cortex and their Bidirectional Modulatory Effects on Neuronal Responses
2008
Mechanisms and Functional Implications of Adult Neurogenesis
2008 Standout
Brain-derived neurotrophic factor in the ventral midbrain–nucleus accumbens pathway: a role in depression
2003
Effectiveness of Antipsychotic Drugs in Patients with Chronic Schizophrenia
2005 Standout
5-HT2 receptors modulate excitatory neurotransmission to cardiac vagal neurons within the nucleus ambiguus evoked during and after hypoxia
2009 StandoutNobel
Molecular, pharmacological and functional diversity of 5-HT receptors
2002 Standout
Abnormalities of 5-hydroxytryptamine metabolism in irritable bowel syndrome
2005
Treatments for schizophrenia: a critical review of pharmacology and mechanisms of action of antipsychotic drugs
2004
The Neuropeptide VGF Produces Antidepressant-Like Behavioral Effects and Enhances Proliferation in the Hippocampus
2007
Functional Connectome of the Striatal Medium Spiny Neuron
2011
Backpropagation and the brain
2020 StandoutNobel
Control of synaptic plasticity in deep cortical networks
2018
From Threat to Fear: The Neural Organization of Defensive Fear Systems in Humans
2009 StandoutNobel
Are the Dorsal and Ventral Hippocampus Functionally Distinct Structures?
2010 Standout
The Effects of the Preferential 5-HT2A Agonist Psilocybin on Prepulse Inhibition of Startle in Healthy Human Volunteers Depend on Interstimulus Interval
2007
5-HT7 Receptor Inhibition and Inactivation Induce Antidepressantlike Behavior and Sleep Pattern
2005
Physiology and Neurobiology of Stress and Adaptation: Central Role of the Brain
2007 Standout
Functional Selectivity and Classical Concepts of Quantitative Pharmacology
2006 StandoutNobel
In Vivo Modulation of the Activity of Pyramidal Neurons in the Rat Medial Prefrontal Cortex by 5-HT2A Receptors: Relationship to Thalamocortical Afferents
2003
Molecular and Cellular Mechanisms of Antidepressant Action
2012
The role of substance P in stress and anxiety responses
2006
Mechanical, thermal and formalin-induced nociception is differentially altered in 5-HT1A−/−, 5-HT1B−/−, 5-HT2A−/−, 5-HT3A−/− and 5-HTT−/− knock-out male mice
2007 StandoutNobel
The free-energy principle: a unified brain theory?
2010 Standout
Optogenetics: 10 years of microbial opsins in neuroscience
2015 Standout
How do antidepressants work? New perspectives for refining future treatment approaches
2017
Dopamine Partial Agonists
2004
Impulsivity, Compulsivity, and Top-Down Cognitive Control
2011 Standout
Glutamatergic dysfunction in schizophrenia: From basic neuroscience to clinical psychopharmacology
2008
Psychedelics
2016 Standout
The neurobiology of psychedelic drugs: implications for the treatment of mood disorders
2010
Stressor Controllability Modulates Stress-Induced Dopamine and Serotonin Efflux and Morphine-Induced Serotonin Efflux in the Medial Prefrontal Cortex
2003
Antidepressant-like effect of m-trifluoromethyl-diphenyl diselenide in the mouse forced swimming test involves opioid and serotonergic systems
2011
Bidirectional communication between sleep and circadian rhythms and its implications for depression: Lessons from agomelatine
2009
Serotonin, the periaqueductal gray and panic
2004
Quantitative analysis of glutamatergic and GABAergic neurons expressing 5‐HT2A receptors in human and monkey prefrontal cortex
2007
Activity of Neurochemically Heterogeneous Dopaminergic Neurons in the Substantia Nigra during Spontaneous and Driven Changes in Brain State
2009
Stress-induced prefrontal reorganization and executive dysfunction in rodents
2008
Recent advances in the neuropsychopharmacology of serotonergic hallucinogens
2014
Parkinson's disease
2009 Standout
Chronic LSD alters gene expression profiles in the mPFC relevant to schizophrenia
2014
Indigenous Bacteria from the Gut Microbiota Regulate Host Serotonin Biosynthesis
2015 Standout
Uncertainty-based competition between prefrontal and dorsolateral striatal systems for behavioral control
2005 Standout
Hallucinogens as discriminative stimuli in animals: LSD, phenethylamines, and tryptamines
2008
Molecular Mechanisms of Depression: Perspectives on New Treatment Strategies
2013 Standout
Effects of activation and blockade of 5-HT2A/2C receptors in the dorsal raphe nucleus on sleep and waking in the rat
2006
New approaches to antidepressant drug discovery: beyond monoamines
2006
The Functional Gastrointestinal Disorders and the Rome III Process
2006 Standout
Aripiprazole, A Novel Atypical Antipsychotic Drug with a Unique and Robust Pharmacology
2003
The Pharmacology of Lysergic Acid Diethylamide: A Review
2008
Neuronal activity in the subthalamic nucleus modulates the release of dopamine in the monkey striatum
2008
Effects of the serotonin 5-HT2A/2C receptor agonist DOI and of the selective 5-HT2A or 5-HT2C receptor antagonists EMD 281014 and SB-243213, respectively, on sleep and waking in the rat
2006
Stress signalling pathways that impair prefrontal cortex structure and function
2009 Standout
A prefrontal cortex–brainstem neuronal projection that controls response to behavioural challenge
2012 Nature
Inhibiting BDNF expression by antisense oligonucleotide infusion causes loss of nigral dopaminergic neurons
2005
Antidepressants and brain monoaminergic systems: a dimensional approach to understanding their behavioural effects in depression and anxiety disorders
2004
Regulation of GABAergic Inhibition by Serotonin Signaling in Prefrontal Cortex: Molecular Mechanisms and Functional Implications
2002
Neurobiology of Depression
2002 Standout
Lysergic acid diethylamide and [−]-2,5-dimethoxy-4-methylamphetamine increase extracellular glutamate in rat prefrontal cortex
2004
mRNA expression of 5-hydroxytryptamine 1B, 1D, and 1F receptors and their role in controlling the release of calcitonin gene–related peptide in the rat trigeminovascular system
2012
Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis
2009 Standout
Tectonigral projections in the primate: a pathway for pre‐attentive sensory input to midbrain dopaminergic neurons
2009
Postmortem studies in mood disorders indicate altered numbers of neurons and glial cells
2000
Molecular genetic responses to lysergic acid diethylamide include transcriptional activation of MAP kinase phosphatase‐1, C/EBP‐β and ILAD‐1, a novel gene with homology to arrestins
2004
Major Depressive Disorder
2008 Standout
Dopamine D4 receptor involvement in the discriminative stimulus effects in rats of LSD, but not the phenethylamine hallucinogen DOI
2008
A Direct Interaction of PSD-95 with 5-HT2A Serotonin Receptors Regulates Receptor Trafficking and Signal Transduction
2003
5-HT2A and 5-HT2C receptor antagonists have opposing effects on a measure of impulsivity: interactions with global 5-HT depletion
2004
Ultrastructural localization of serotonin2A receptors in the middle layers of the rat prelimbic prefrontal cortex
2003
Serotonin, tryptophan metabolism and the brain-gut-microbiome axis
2014 Standout
The "two-headed" latent inhibition model of schizophrenia: modeling positive and negative symptoms and their treatment
2003
Mind-altering microorganisms: the impact of the gut microbiota on brain and behaviour
2012 Standout
KYNURENINE METABOLITES AND INFLAMMATION MARKERS IN DEPRESSED PATIENTS TREATED WITH FLUOXETINE OR COUNSELLING
2008
Serotonin Modulates Fast-Spiking Interneuron and Synchronous Activity in the Rat Prefrontal Cortex through 5-HT1Aand 5-HT2AReceptors
2010
Dissociable Contribution of 5-HT1A and 5-HT2A Receptors in the Medial Prefrontal Cortex to Different Aspects of Executive Control such as Impulsivity and Compulsive Perseveration in Rats
2005
Dopamine in Motivational Control: Rewarding, Aversive, and Alerting
2010 Standout
Endogenous serotonin and serotonin2Creceptors are involved in the ability of M100907 to suppress cortical glutamate release induced by NMDA receptor blockade
2008
Intra-prefrontal 8-OH-DPAT and M100907 improve visuospatial attention and decrease impulsivity on the five-choice serial reaction time task in rats
2003
Evaluation of Platelet Activation in Depressed Patients With Ischemic Heart Disease After Paroxetine or Nortriptyline Treatment
2000
The molecular neurobiology of depression
2008 StandoutNature
Lateral Habenula Stimulation Inhibits Rat Midbrain Dopamine Neurons through a GABAA Receptor-Mediated Mechanism
2007
Optogenetics in Neural Systems
2011 Standout
Psilocybin-induced spiritual experiences and insightfulness are associated with synchronization of neuronal oscillations
2015
The debate over dopamine’s role in reward: the case for incentive salience
2006 Standout
Serotonergic modulation of the limbic system
2005
The neurobiology of depression and antidepressant action
2012
Fluorine in Pharmaceutical Industry: Fluorine-Containing Drugs Introduced to the Market in the Last Decade (2001–2011)
2013 Standout
Geometric and Electronic Structure/Function Correlations in Non-Heme Iron Enzymes
1999 Standout
Classical hallucinogens as antidepressants? A review of pharmacodynamics and putative clinical roles
2014
Evidence for Possible Involvement of 5-HT2BReceptors in the Cardiac Valvulopathy Associated With Fenfluramine and Other Serotonergic Medications
2000
Brain monoamine oxidase A inhibition in cigarette smokers
1996
Essential Role of BDNF in the Mesolimbic Dopamine Pathway in Social Defeat Stress
2006 StandoutScience
Marine Indole Alkaloids: Potential New Drug Leads for the Control of Depression and Anxiety
2010 Standout
When Fear Is Near: Threat Imminence Elicits Prefrontal-Periaqueductal Gray Shifts in Humans
2007 StandoutScienceNobel
Depression and Coronary Heart Disease
2008 Standout
Synthesis and Structure–Activity Relationships ofN-Benzyl Phenethylamines as 5-HT2A/2CAgonists
2014
Pterin-Dependent Amino Acid Hydroxylases
1996
ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease
2006 Standout
Dioxygen Activation at Mononuclear Nonheme Iron Active Sites: Enzymes, Models, and Intermediates
2004 Standout
Expression of α1-adrenergic receptors in rat prefrontal cortex: cellular co-localization with 5-HT2A receptors
2012
Head‐twitch response in rodents induced by the hallucinogen 2,5‐dimethoxy‐4‐iodoamphetamine: a comprehensive history, a re‐evaluation of mechanisms, and its utility as a model
2012
Htr2a gene and 5-HT2A receptor expression in the cerebral cortex studied using genetically modified mice
2010
Transcriptome Fingerprints Distinguish Hallucinogenic and Nonhallucinogenic 5-Hydroxytryptamine 2A Receptor Agonist Effects in Mouse Somatosensory Cortex
2003
Serotonin Receptors
2008
Autoregulatory properties of dorsal raphe 5-HT neurons: Possible role of electrotonic coupling and 5-HT1D receptors in the rat brain
1996
Duloxetine versus escitalopram and placebo in the treatment of patients with major depressive disorder: onset of antidepressant action, a non-inferiority study
2007
Mechanism of the 5-hydroxytryptamine 2A receptor-mediated facilitation of synaptic activity in prefrontal cortex
2007
Serotonin receptor knockouts: A moody subject
1998 StandoutNobel
2008 Focused Update Incorporated Into the ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease
2008 Standout
5-HT2AReceptor-Mediated Regulation of Brain-Derived Neurotrophic Factor mRNA in the Hippocampus and the Neocortex
1997
LSD-assisted psychotherapy for anxiety associated with a life-threatening disease: A qualitative study of acute and sustained subjective effects
2014
Separate Neural Systems Value Immediate and Delayed Monetary Rewards
2004 StandoutScience
Hallucinogens
2004 Standout
Prediction of immediate and future rewards differentially recruits cortico-basal ganglia loops
2004
Works of Pau Celada being referenced
The therapeutic role of 5-HT1A and 5-HT2A receptors in depression.
2004
Preclinical and clinical characterization of the selective 5‐HT1Areceptor antagonist DU‐125530 for antidepressant treatment
2011
The Hallucinogen DOI Reduces Low-Frequency Oscillations in Rat Prefrontal Cortex: Reversal by Antipsychotic Drugs
2008
Simultaneous projections from prefrontal cortex to dopaminergic and serotonergic nuclei
2010
Local infusion of brain-derived neurotrophic factor modifies the firing pattern of dorsal raphé serotonergic neurons
1996
Serotonin 5-HT1A Receptors as Targets for Agents to Treat Psychiatric Disorders: Rationale and Current Status of Research
2013
Plasma 5‐Hydroxyindoleacetic Acid as an Indicator of Monoamine Oxidase‐A Inhibition in Rat Brain and Peripheral Tissues
1993
Origin and functional role of the extracellular serotonin in the midbrain raphe nuclei
2002
How does pindolol improve antidepressant action?
2001
The role of 5‐HT1B receptors in the regulation of serotonin cell firing and release in the rat brain
2001
Gabaergic control of rat substantia nigra dopaminergic neurons: role of globus pallidus and substantia nigra pars reticulata
1999
Strategies for producing faster acting antidepressants
2005
The natural hallucinogen 5-MeO-DMT, component of Ayahuasca, disrupts cortical function in rats: reversal by antipsychotic drugs
2014
The effects of brofaromine, a reversible MAO-A inhibitor, on extracellular serotonin in the raphe nuclei and frontal cortex of freely moving rats
1994
Striatal, pallidal, and pars reticulata evoked inhibition of nigrostriatal dopaminergic neurons is mediated by GABAA receptors in vivo
1999
p‐Chlorophenylalanine Increases Tryptophan‐5‐Hydroxylase mRNA Levels in the Rat Dorsal Raphe: A Time Course Study Using In Situ Hybridization
1993
Serotonin and 5-hydroxyindoleacetic acid in plasma. Potential use as peripheral measures of MAO-A activity
1990
Involvement of 5-HT1AReceptors in Prefrontal Cortex in the Modulation of Dopaminergic Activity: Role in Atypical Antipsychotic Action
2005
Effects of acute and chronic treatment with fluvoxamine on extracellular and platelet serotonin in the blood of major depressive patients. Relationship to clinical improvement
1992
Activation of pyramidal cells in rat medial prefrontal cortex projecting to ventral tegmental area by a 5-HT1A receptor agonist
2005
GABAergic Control of the Firing Pattern of Substantia Nigra Dopaminergic Neurons
1997
Pindolol Augmentation of Antidepressant Response
2006
In vivo actions of aripiprazole on serotonergic and dopaminergic systems in rodent brain
2007
The activation of 5‐HT2A receptors in prefrontal cortex enhances dopaminergic activity
2005
Reduction of in vivo striatal 5-hydroxytryptamine release by 8-OH-DPAT after inactivation of Gi/Go proteins in dorsal raphe nucleus
1994
Monoamine oxidase inhibitors increase preferentially extracellular 5-hydroxytryptamine in the midbrain raphe nuclei. A brain microdialysis study in the awake rat
1993
Effects of chronic treatment with dexfenfluramine on serotonin in rat blood, brain and lung tissue
1994
Plasma Free 5HT and Platelet 5HT in Depression: Case-Control Studies and the Effect of Antidepressant Therapy
1991
Antipsychotic drugs reverse the disruption in prefrontal cortex function produced by NMDA receptor blockade with phencyclidine
2007
Monoamine Oxidase Inhibitors Phenelzine and Brofaromine Increase Plasma Serotonin and Decrease 5-Hydroxyindoleacetic Acid in Patients with Major Depression
1992
Control of Serotonergic Function in Medial Prefrontal Cortex by Serotonin-2A Receptors through a Glutamate-Dependent Mechanism
2001
Control of Dorsal Raphe Serotonergic Neurons by the Medial Prefrontal Cortex: Involvement of Serotonin-1A, GABAA, and Glutamate Receptors
2001
Serotonin modulation of cortical neurons and networks
2013
Control of serotonergic function in medial prefrontal cortex by serotonin-2A receptors through a glutamate-dependent mechanism
2020